Aion Therapeutic Announces Closing of Non-Brokered Private Placement Post published:December 23, 2020 Post category:Press Release
Ehave KetaDASH Subsidiary Announces Intent to Battle Major Depression through Home Delivery of Ketamine Post published:December 23, 2020 Post category:Press Release
Revive Therapeutics Provides Update on FDA Phase 3 Clinical Trial for Bucillamine in COVID-19 with Plans on Emergency Use Access Post published:December 23, 2020 Post category:Press Release
Red Light Holland Looking To Receive Exemption for Controlled Substances from Government of Canada, Engages Wellington Dupont Public Affairs Post published:December 23, 2020 Post category:Press Release
BetterLife Welcomes Psychedelic Industry Leaders to the Senior Management Team Post published:December 23, 2020 Post category:Press Release
Psyched Wellness Commences Pre-Clinical Trials of Amanita Muscaria Post published:December 23, 2020 Post category:Press Release
Havn Life Sciences and Nesters Market, a Leading Canadian Retailer of Natural Health and Wellness Products, Announce an Authorized Products Listing Post published:December 22, 2020 Post category:Press Release
Mindset Pharma to Commence Trading on the CSE on December 23, 2020 Under the Symbol “MSET” Post published:December 22, 2020 Post category:Press Release
Novamind Receives CSE Conditional Listing Approval Under the Ticker “NM” Post published:December 22, 2020 Post category:Press Release
MagicMed Industries Announces the Establishment of Psilocybin-Derivatives Portfolio and Launch of Candidate Selection Program Post published:December 22, 2020 Post category:Press Release